A sympathetic blocking agent, bretylium tosylate (Darenthin), in the treatment of hypertension
- PMID: 13695220
Item in Clipboard
A sympathetic blocking agent, bretylium tosylate (Darenthin), in the treatment of hypertension
J Lab Clin Med.
1961 Feb.
No abstract available
Similar articles
-
Sympathetic blockade in treatment of hypertension. Clinical trial of bretylium tosylate.Br Med J. 1960 Oct 8;2(5205):1049-53. doi: 10.1136/bmj.2.5205.1049. Br Med J. 1960. PMID: 13763868 Free PMC article. No abstract available.
-
[Bretylium tosylate (Darenthin). Report of an experiment on the clinical significance of bretylium tosylate in the treatment of hypertension].Ned Tijdschr Geneeskd. 1961 Jun 24;105:1260-6. Ned Tijdschr Geneeskd. 1961. PMID: 13788182 Dutch. No abstract available.
-
Clinical trial of bretylium tosylate (darenthin) in hypertension.Cent Afr J Med. 1960 May;6:197-8. Cent Afr J Med. 1960. PMID: 14445704 No abstract available.
-
Bretylium tosylate: a review.Am J Hosp Pharm. 1979 Sep;36(9):1189-92. Am J Hosp Pharm. 1979. PMID: 386786 Review.
-
Bretylium tosylate: profile of the only available class III antiarrhythmic agent.Clin Ther. 1985;7(2):205-24. Clin Ther. 1985. PMID: 3886143 Review.